Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations

被引：1
作者：
Cuellar, Sonia L. Betancourt [1 ]
Palacio, Diana P. [2 ]
Benveniste, Marcelo F. [1 ]
Carter, Brett W. [1 ]
Hofstetter, Wayne L. [1 ]
Marom, Edith M. [1 ,3 ,4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, 1515 Holcombe Blvd, Houston, TX 77030 USA
[2] Univ Anzona, Med Ctr, Dept Diagnost Radiol, Tucson, AZ USA
[3] Chaim Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel
[4] Tel Aviv Univ, Tel Aviv, Israel
来源：
SEMINARS IN ULTRASOUND CT AND MRI | 2017年 / 38卷 / 06期
关键词：
SQUAMOUS-CELL CARCINOMA; METABOLIC TUMOR VOLUMES; LYMPH-NODE; ESOPHAGOGASTRIC JUNCTION; NEOADJUVANT THERAPY; FDG-PET; ENDOSCOPIC ULTRASOUND; DISTANT METASTASES; PROGNOSTIC-FACTOR; HISTOLOGIC TYPE;
D O I：
10.1053/j.sult.2017.07.008
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Squamous cell carcinoma and adenocarcinoma represent approximately 98% of esophageal malignant tumors. During the last 30 years, the incidence of adenocarcinoma has increased in Western countries (including the USA) where adenocarcinoma currently represents more than 60% of esophageal malignancies, although, worldwide, squamous cell carcinoma continues to be the predominant histologic type. Integrated positron emission tomography or computed tomography with 2-Efluorine181 fluro-2-deoxy-o-glucose is used in many institutions routinely as a tool in the initial staging and then repeated after therapy for the assessment of response to neoadjuvant therapy and detection of recurrent disease in patients with esophageal carcinoma. As with any other imaging modality, 2-[fluorine18] fluro-2-deoxy-D-glucose-positron emission tomography or computed tomography has strengths and limitations that should be understood in order to maximize its utility. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码：571 / 583
页数：13
相关论文
共 50 条
[31]   The Role of Positron Emission Tomography/Computed Tomography in the Diagnosis of Pleural Diseases [J].
Orki, A. ;
Akin, O. ;
Tasci, A. E. ;
Ciftci, H. ;
Urek, S. ;
Falay, O. ;
Kutlu, C. A. .
THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 (04) :217-221
[32]   Positron Emission Tomography/Computed Tomography Transformation of Oncology: Musculoskeletal Cancers [J].
Broski, Stephen M. .
PET CLINICS, 2024, 19 (02) :217-229
[33]   Positron Emission Tomography-Computed Tomography Imaging for Malignancies in Women [J].
Viswanathan, Chitra ;
Bhosale, Priya R. ;
Shah, Shetal N. ;
Vikram, Raghunandan .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2013, 51 (06) :1111-+
[34]   Expert Opinions on Positron Emission Tomography and Computed Tomography Imaging in Lymphoma [J].
Delbeke, Dominique ;
Stroobants, Sigrid ;
de Kerviler, Eric ;
Gisselbrecht, Christian ;
Meignan, Michel ;
Conti, Peter S. .
ONCOLOGIST, 2009, 14 :30-40
[35]   Role of Positron Emission Tomography-Computed Tomography in Pulmonary Neoplasms [J].
Shreve, Paul ;
Faasse, Todd .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2013, 51 (05) :767-+
[36]   The prognostic value of positron emission tomography/computed tomography in pulmonary metastasectomy [J].
Shiono, Satoshi ;
Endo, Makoto ;
Suzuki, Katsuyuki ;
Yarimizu, Kei ;
Hayasaka, Kazuki .
JOURNAL OF THORACIC DISEASE, 2018, 10 (03) :1738-1746
[37]   Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer [J].
Choi, Jeongmin ;
Kim, Sang Gyun ;
Kim, Joo Sung ;
Jung, Hyun Chae ;
Song, In Sung .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2010, 24 (06) :1380-1386
[38]   Comparison of 18F-fluorothymidine Positron Emission Tomography/Computed Tomography and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer [J].
Mori, Mio ;
Fujioka, Tomoyuki ;
Ichikawa, Ryota ;
Inomata, Reina ;
Katsuta, Leona ;
Yashima, Yuka ;
Yamaga, Emi ;
Tsuchiya, Junichi ;
Hayashi, Kumiko ;
Kumaki, Yuichi ;
Oda, Goshi ;
Nakagawa, Tsuyoshi ;
Onishi, Iichiroh ;
Kubota, Kazunori ;
Tateishi, Ukihide .
TOMOGRAPHY, 2022, 8 (05) :2533-2546
[39]   Is combined 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography superior to Positron Emission Tomography or Computed Tomography alone for diagnosis, staging and restaging of pancreatic lesions ? [J].
Casneuf, Veerle ;
Delrue, Louke ;
Kelles, Annemarie ;
Van Damme, Nancy ;
Van Huysse, Jacques ;
Berrevoet, Frederik ;
De Vos, Martine ;
Duyck, Philippe ;
Peeters, Marc .
ACTA GASTRO-ENTEROLOGICA BELGICA, 2007, 70 (04) :331-338
[40]   Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma [J].
Qualliotine, J. R. ;
Mydlarz, W. K. ;
Chan, J. Y. K. ;
Zhou, X. ;
Wang, H. ;
Agrawal, N. .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2015, 129 (12) :1213-1219
12345